Based on the Arcadia Biosciences Inc stock forecast from 1 analysts, the average analyst target price for Arcadia Biosciences Inc is USD 12.00 over the next 12 months. Arcadia Biosciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Arcadia Biosciences Inc is Slightly Bullish , which is based on 4 positive signals and 3 negative signals. At the last closing, Arcadia Biosciences Inc’s stock price was USD 3.03. Arcadia Biosciences Inc’s stock price has changed by +2.36% over the past week, -3.81% over the past month and +49.25% over the last year.
No recent analyst target price found for Arcadia Biosciences Inc
No recent average analyst rating found for Arcadia Biosciences Inc
Company Overview Arcadia Biosciences Inc
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. Read Less
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingre...Read More
Frequently Asked Questions About Arcadia Biosciences Inc (RKDA) Stock
Based on ratings from 1 analysts Arcadia Biosciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 3 buy, sell and hold ratings.
Unfortunately we do not have enough data on RKDA's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for RKDA is USD 12.00 over the next 12 months. The maximum analyst target price is USD 12 while the minimum anlayst target price is USD 12.
RKDA stock's Price/Earning ratio is 5.26.
Our analysis grades RKDA stock's Price / Earning ratio at A-. This means that RKDA stock's Price/Earning ratio is above 9.999999999999998% of the stocks in the Packaged Foods sector in the NSD exchange.
Based on this RKDA may be undervalued for its sector.
The last closing price of RKDA's stock was USD 3.03.
The most recent market capitalization for RKDA is USD 4.30M.
Based on targets from 1 analysts, the average taret price for RKDA is projected at USD 12.00 over the next 12 months.
This means that RKDA's stock price may go up by +296.04% over the next 12 months.
We can't find any ETFs which contains Arcadia Biosciences Inc's stock.
As per our most recent records Arcadia Biosciences Inc has 21 Employees.
Arcadia Biosciences Inc's registered address is 5950 Sherry Lane, Dallas, TX, United States, 75225.
You can get more information about it from Arcadia Biosciences Inc's website at https://www.arcadiabio.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Frequently Asked Questions About Arcadia Biosciences Inc (RKDA) Stock
Based on ratings from 1 analysts Arcadia Biosciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 3 buy, sell and hold ratings.
Unfortunately we do not have enough data on RKDA's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for RKDA is USD 12.00 over the next 12 months. The maximum analyst target price is USD 12 while the minimum anlayst target price is USD 12.
RKDA stock's Price/Earning ratio is 5.26.
Our analysis grades RKDA stock's Price / Earning ratio at A-. This means that RKDA stock's Price/Earning ratio is above 9.999999999999998% of the stocks in the Packaged Foods sector in the NSD exchange.
Based on this RKDA may be undervalued for its sector.
The last closing price of RKDA's stock was USD 3.03.
The most recent market capitalization for RKDA is USD 4.30M.
Based on targets from 1 analysts, the average taret price for RKDA is projected at USD 12.00 over the next 12 months.
This means that RKDA's stock price may go up by +296.04% over the next 12 months.
We can't find any ETFs which contains Arcadia Biosciences Inc's stock.
As per our most recent records Arcadia Biosciences Inc has 21 Employees.
Arcadia Biosciences Inc's registered address is 5950 Sherry Lane, Dallas, TX, United States, 75225.
You can get more information about it from Arcadia Biosciences Inc's website at https://www.arcadiabio.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RKDA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
